Effect of essential oil on hypertrophic scars by Rahman, Ave Olivia et al.
MEDISAINS - VOL. 19 NO. 1 (2021) 15-20 
 
 
https://doi.org/10.30595/medisains.v19i1.10192   
©(2021) by the Medisains Journal. Readers may use this article as long as the work is properly cited, the use is educational and not for 
profit, and the work is not altered. More information is available at Attribution-NonCommercial 4.0 International. 
 
Original Article 
Effect of essential oil on hypertrophic scars 
Ave Olivia Rahman 1, Humaryanto 1, Anati Purwakanthi 1, Charles Apul Simanjuntak 1 
1 Faculty of Medicine and health sciences, University of Jambi, Jambi, Indonesia 
 
ARTICLE INFORMATION  A B S T R A C T  
 
Received: March 25, 2021 
Revised: May 24, 2021 
Available online: June 07, 2021 
 
Background: Hypertrophic scars are abnormal scars resulted from a disrupted 
wound healing process. Hypertrophic scars can affect the body aesthetic of the 
sufferers, but, on the other hand, conventional therapy has not been optimally 
effective. The application of essential oil combinations as an alternative therapy 
for hypertrophic scars has not been scientifically proven.  
Purposes: This study was to determine the effectiveness of the essential oil as 
a hypertrophic scar therapy. 
Methods: This study used a pre and post-test design. As many as 24 subjects 
aged 17-25 years with hypertrophic scars were given essential oil combinations 
every morning and evening for six months. Assessment of hypertrophic scars 
was done using the POSAS (Patient and Observer Scar Assessment Scale). 
Results: The results showed that the POSAS score decreased after the essen-
tial oil combination administration for six months, 14.40±6.08 vs. 22.67±8.31 
(p<0.001).  
Conclusion: the combination of essential oil oils used in this study reduces hy-
pertrophic scars based on the POSAS assessment. 
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Hypertrophic scars are abnormal scars resulted from dis-
ruption of the physiological wound healing process. A dis-
turbance in the balance between fibroblast proliferation or 
collagen synthesis and its degradation process causes 
these hypertrophic scars. Each year in developing coun-
tries, 100 million sufferers are complaining about scars. 
About 55 million scar cases occur due to elective surgical 
wounds, and 25 million scar cases occur in trauma sur-
gery. These hypertrophic scars could affect the body im-
age of the sufferers.1 
 
Current treatments of hypertrophic scars are, among oth-
ers, intralesional corticosteroid injection, cryotherapy, and 
laser therapy. The effectiveness of these therapies varies 
widely, and several recurrences were found.1,2 The devel-
opment of alternative hypertrophic scar therapy is needed 
for patients, especially those experiencing recurrences 
with conventional treatment. Several alternative therapies 
for hypertrophic scars that have been proven are topical 
silicone gel sheeting (SGS), garlic extract, and several fla-
vonoids, such as quercetin, which can inhibit fibroblast 
proliferation.1,3,4 
 
Essential oils are currently widely used by society for treat-
ing several diseases, including skin diseases.5 Essential 
oils could penetrate the skin and are distributed under the 
skin.6 Essential oils are extracts from natural ingredients 
that are oil/lipid-based. The combination of Helichrysum 
italicum, lavender, lemongrass, patchouli, and myrrh is 
one of several essential oil combination ingredients be-
lieved as hypertrophic wound therapies. Based on previ-
ous research, these essential oils have antibacterial and 
antioxidant effects and fibroblasts and collagen. Helichry-
sum sp essential oil concentration of 0.01% can signifi-
cantly inhibit the production of type I and III collagen. 
Patchouli essential oil concentration of 0.00033% has anti-
proliferative properties and inhibits the production of PAI-
1 (plasminogen activator inhibitor 1).7 Lemongrass essen-
tial oil can reduce biomarkers of type I and III collagen tis-
sue remodeling and epidermal growth factor receptors.8 
Topical application of lavender oil on the wound results in 
decreased expression of type III collagen.9 Myrrh oil can 
increase the proliferation of skin epithelial cells and in-
crease collagen cross-linking.10 
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However, there is no scientific evidence regarding the ef-
fectiveness of this combination as a hypertrophic scar ther-
apy. Thus, this study is conducted to determine the effec-
tiveness of the essential oil combination prescription in re-
ducing hypertrophic scars. 
METHOD 
Study Design 
This study design was a quasi-experimental study using 
pre and post-test design. 
Settings and Respondents 
The research was conducted during June-December 2019 
at the Faculty of Medicine, and Health Sciences, Jambi 
University, Jambi. The inclusion criteria of research sub-
jects were college students aged between 17 and 25 years 
and owning hypertrophic scars. Hypertrophic scars can be 
identified from their characteristics that are merely limited 
to the wound size.3,4 The exclusion criteria were signs of 
allergies to the essential oil combination used in the study 
and underwent a conventional hypertrophic scar therapy, 
such as corticosteroid injection. The allergy test was car-
ried out by applying the essential oil combination to the 
normal skin area and looked for signs of allergies, forms of 
redness, or itching. This study's research subjects were 24 
people, eight men and 16 women (1 subject could have 
more than one hypertrophic scar)—sampling using a pur-
posive sampling method. Every subject participating in this 
study had provided informed consent. 
Experimental Procedure 
The essential oil used was from a well-known essential oil 
brand in Indonesia. The essential oil combination con-
sisted of 1.67% Helichrysum italicum, 1% lavender, 1.3% 
lemongrass, 0.6% patchouli, 0.83% myrrh, and up to 100% 
vegetable oil. The essential oil was packaged in a dark 
bottle with a roller tip for easy application. The research 
subjects were given a combination of essential oils on hy-
pertrophic scar tissue for six months at a dose of two times 
a day, morning and night.  The amount of essential oil that 
is applied is sufficient not to spill and cover all scar areas. 
Subjects were asked to write the signs when applying the 
essential oil combination in the morning and night. 
The Variable, Instrument, and Measurement 
The assessment of hypertrophic scars was carried out us-
ing the patient and observer scar assessment scale 
(POSAS scoring table) consisting of assessments from 
subjects and observer.11 POSAS assessments were car-
ried out before treatment (pre-test) and six months after 
treatment (post-test). The subject should give each a score 
from 1-10 to the pain, itching, color difference, stiffness, 
thickness, and irregularity of the scar. Meanwhile, the ob-
server should give each a score from 1-10 to observe vas-
cularity, pigmentation, thickness, relief, and pliability of 
scars. Score 1 refers to no complain, as normal skin. While 
score 10 refers to the worst scar imageable or very differ-
ent as normal skin. Observer POSAS score is done by cal-
culating the total score from each observation result of an 
observer. Adherence assessment was calculated by the 
percentage of usage frequency obtained daily. 
Data Analysis 
Data were presented as percentages and analyzed using 
the paired T-test with a significant level of p<0.05 as the 
data is normally distributed. 
Ethical Consideration 
This research received ethical approval from the Faculty 
of Medicine and Health Sciences, the University of Jambi, 
under decree number B/635/UN.21.8/PT.01.04/2019. 
RESULTS  
The characteristics of the research subjects are presented 
in Table 1. Of the 24 subjects, most were female and aged 
20 years. Out of a total of 37 scars suffered by all subjects, 
the scarring mainly occurred in the knee (37,8%), which 
was caused by trauma (54%), with a time-varying from 7-
204 months. 
   
Table 1. Characteristics of Subjects with Hypertrophic 
Scars (n=24) (n=24) 
Characteristic Result 
Age (mean, min-max), years 20 (18-22) 
Gender  
Male 8 (33.3%) 
Female  16 (66.7%) 
Hypertrophic scar location  
Thigh 1 (2.7)* 
Calf 1 (2.7)* 
Instep 1 (2.7)* 
Knee 14 (37.8)* 
Upper arm 1 (2.7)* 
Forearm  2 (5.4)* 
Back of the hand 3 (8.1)* 
Ankle 2 (5.4)* 
Toes 1 (2.7)* 
Wrist 2 (5.4)* 
Fingers 2 (5.4)* 
Ankle 4 (10.8) 
Stomach 2 (5.4)* 
Chest 1 (2.7)* 
Cause of scar  
Surgical wound 11 (29.7)* 
Burns 2 (5.4)* 
Torn from trauma 20 (54)* 
Chemical trauma 1 (2.7)* 
Scratching trauma 2 (5.4)* 
Smallpox marks 1 (2.7)* 
Scar onset (in months) me-
dian (min-max) 
60 (7-204) 
* percentage of 37 hypertrophic scars 
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The mean POSAS score according to subjects' assess-
ment before (pre) the essential oil combination administra-
tion was 22.67±8.31, while the score after (post) the es-
sential oil combination was 14.40±6.08 (p<0.001). Accord-
ing to the observers' assessment, the total mean score of 
observations before the essential oil combination admin-
istration was 20.19±6.6, and the score after the essential 
oil combination administration was 13.13±4.08 (p<0.001). 
There was a significant decrease in the POSAS score be-
fore and after the essential oil combination administration 
based on the assessment of the subjects and observers 
(Figure 1).  
 
The mean percentage of compliance in applying essential 
oil is 73.80% (Mode is 80%; minimum 20%; maximum 
95%). The compliance sheet observations revealed that 
the subjects used the essential oil once a day and skipped 
the morning or evening schedule. Changes in the hyper-
trophic scars before and after essential oil administration 
can be seen in Figure 2. 
 
Figure 1. POSAS scores before and after six months of 
treatment based on the assessment of subjects (blue) and 
observers (orange) 
 
Figure 2. Photos of Hypertrophic Scars. (A) Photos of hypertrophic scars code 04A located in the knee, 156 months 
onset, before essential oil combination administration. The hypertrophic scar code 04A has a subject’s total POSAS 
score of 47 and a observer’s total POSAS score of 29. B, C, D, and E are photos of hypertrophic scars after two weeks, 
one month, two months, and six months after oil application, respectively. The percentage of application adherence is 
95%. Hypertrophic scars thinning appears as indicated by arrows. The subject’s total POSAS score decreases to 25, 
and the observers’ total POSAS score decreases to 15. Both subjects and observers noticed the changes in color, 
size, and elasticity of the hypertrophic scars. The subject did not feel pain or itching after the essential oil combination 
administration. 
DISCUSSION 
Hypertrophic scars are abnormal scars that arise due to 
irregularities in the physiological wound healing process.3,4 
Hypertrophic scars can be identified from their character-
istics that are merely limited to the wound size and usually 
occur 4-8 weeks after trauma.  Hypertrophic scars can be 
caused by irritations or deep wounds that reach the der-
mis.12 The deep wound stimulates skin fibroblasts to pro-
duce collagen and inflammatory mediators, such as trans-
forming growth factor-beta 1 (TGF-beta1).13,14 
 
A balance disorder between deposition and degradation of 

















Mean of POSAS Score
A B C D E 
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normal scarring. Hypertrophic scars are caused by in-
creased fibroblast proliferative capacity and or fibroblast 
apoptotic resistance. There are mutations in exon 7 of fi-
broblasts. Also, a dysregulation transforming growth factor 
β (TGF-β), which is the main stimulator in collagen produc-
tion, overexpression of TGF- β will cause hypertrophic 
scars. Disturbances in the inflammatory phase can also 
cause abnormal scars. Cytokines, such as IL-4, IL-5, IL-
10, and IL-13, are known to be involved in forming abnor-
mal scars.3,4 
 
The best therapy of hypertrophic scar is prevention by in-
fluencing the signaling processes in cells involved in the 
excessive proliferation of fibroblasts and collagen, reduc-
ing inflammation, skin tension, and strain.15,16 Type I or III 
collagen reduction is one of the therapeutic targets in hy-
pertrophic scars.17 For hypertrophic scar, available treat-
ment options are pressure dressings, laser resurfacing, 
topical or intralesional agents. One of intralesional agent 
is corticosteroids. Corticosteroids can inhibit fibroblast 
growth, promote collagen degradation, inhibit TGF-beta 1 
expression and induce apoptosis in fibroblasts.15 Some 
essential oils can affect the wound healing process in-
volved in scar tissue formation.  
 
In this study, The statistical results of the POSAS score at 
post-therapy with essential oil were significantly lower than 
that before therapy. This decrease in mean POSAS score 
implies that the combination of essential oils works syner-
gistically to reduce hypertrophic scars. This is consistent 
with research conducted by Puri and Talwar (2009), where 
the application of silicone gel which has been widely used 
as a hypertrophic scar therapy, has been proven effective 
in reducing rather than eliminating hypertrophic scars.18 At 
two weeks of use, the study subjects began to feel 
changes. The subjects who initially felt pain in the scar tis-
sue area when obtaining pressure became less of pain. 
Based on the photos, after two months of use, there were 
no remarkable changes. The application was continued for 
six months to see the possibility of a delayed effect con-
sidering the relatively long age of hypertrophic scars 
among the study subjects. After six months of administra-
tion, scar tissue was only reduced and could not disappear 
completely.  
 
A combination of these essential oils has anti-inflamma-
tory activities, fibroblast, and collagen reduction. Some 
studies showed that helichrysum essential oil and 
lemongrass inhibited type I and III collagen production. 
Lemongrass essential oil, lavender, and patchouli also 
have anti-proliferative activity on skin fibroblast cells.7,8 
Lavender oil is known to have a linalyl acetate component, 
which is cytotoxic to fibroblasts and endothelial cells, re-
ducing scarring.19,20 Helichrysum italicum, patchouli, 
lemongrass, and lavender have anti-inflammatory activi-
ties.7,8,21-23 Meanwhile, Myrrh essential oil has antibacterial 
activities.10 Antibacterial and Anti-inflammatory activities 
can prevent excessive inflammatory responses that can 
interfere with the normal wound healing process lead to 
hypertrophic scar formation.3,4,15 
 
Hypertrophic scars in the subjects of this study were scars 
occurring a long time ago. The essential oil may work by 
influencing the factors involved in the degradation of ma-
ture collagen. The age of hypertrophic scars may affect the 
effectiveness of these essential oils. Based on the studies 
that have been mentioned above, these essential oil has 
anti-proliferative fibroblast and collagen, and only lavender 
has a cytotoxic effect on fibroblast. As is known, fibroblast 
proliferation occurs during the proliferation phase of the 
wound healing process on days 7-14.3,4 herefore, it is likely 
that the earlier timing of this oil in the event of injury will 
likely lead to a more effective reduction of scar tissue. Fur-
ther research needs to be carried out on subjects with 
early hypertrophic scars or even when the injury occurs in 
individuals who possibly develop abnormal scarring. 
 
Other studies have shown different results regarding the 
use of essential oils for wounds and scarring. The 85% 
methanol extract of Helichrysum graveolens has anti-hya-
luronidase and anti-collagenase activities.21 Hyaluroni-
dase and collagenase degrade the excessive extracellular 
matrix.  Patchouli extract is known to reduce MMP1 and 
MMP3 expression.22,23 MMP is an enzyme that functions 
in the degradation of the extracellular matrix. The lavender 
extract can accelerate epithelialization and increase FGF2 
(fibroblast growth factor-2)19, upregulation of TGF-β ex-
pression, increased synthesis of type I and III collagen at 
the beginning of the phase, and replacement type III colla-
gen to type I at a later stage and fibroblast differentiation.9 
The examination of Myrrh extract on fibroblasts showed 
that the extract increased fibroblast proliferation, acceler-
ated fibroblast cell cycle, and upregulated type III but not 
type I collagen mRNA expression.24 A study has shown 
that myrrh extract inhibited collagenase MMP1 and anti-
tyrosinase activity and had no effect on type I of procolla-
gen.25 The working mechanism of this combination oil on 
hypertrophic scars needs further investigation.   
 
Limitation in this study, assessing the volume and size of 
the scar that is more objective and can be compared quan-
titatively was not performed due to limited tools. Also, there 
was no control group in this study. The effect of essential 
oil combination on hypertrophic scars was assessed using 
the POSAS score. POSAS is a scar tissue assessment in-
volving both the patient and the observer. Several studies 
have shown that POSAS is reliable and valid.26 However, 
POSAS assessments are semi-qualitative.27 The relatively 
long duration of the study that can affect the compliance 
on applying the essential oils is also a weakness of this 
study. 
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CONCLUSIONS AND RECOMMENDATION 
Administration of a combination of Helichrysum, lavender, 
lemongrass, patchouli, and myrrh essential oils for six 
months can reduce but cannot remove the long-formed 
scar tissue.  This study was unable to assess the mecha-
nism of essential oil combinations in reducing scars. This 
study was also unable to evaluate the active substances 
that primarily contribute to reducing hypertrophic scars. 
Further research is needed to determine the mechanism 
pathways and active substances in the essential oil com-
binations on hypertrophic scars. 
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